Abstract

The first imidazolyl “upper-rim” derivatives of 1,3,5-triaza-7-phoshaadamantane (PTA), namely, 1-methylimidazolyl-(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]dec-6-yl)methanol (2, PTA-CH(1-MeIm)OH) and bis(1-methylimidazolyl)(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]dec-6-yl)methanol (3, PTA-C(1-MeIm)2OH), were synthesized in fair yields by reaction of PTA-Li with 1-methyl-2-imidazole carboxyaldehyde and bis(N-methylimidazole-2-yl) ketone, respectively. Compounds 2 and 3 exhibit higher water solubility than most upper-rim derivatives of PTA. The two ligands reacted cleanly with [Ru(η6-p-cymene)Cl2]2 in refluxing CHCl3 to form κ2-P,N-[(η6-p-cymene)Ru{PTA-CH(1-MeIm)OH}Cl]Cl (8) and κ2-P,N-[(η6-p-cymene)Ru{PTA-C(1-MeIm)2OH}Cl]Cl (9). Ligands phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]dec-6-yl)methanol (PZA) and 4′-dimethylaminophenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]dec-6-yl)methanol (PZA-NMe2) were also used to coordinate to Ru, and the corresponding κ1-P-[(η6-p-cymene)Ru(PZA)Cl2] (6) and κ1-P-[(η6-p-cymene)Ru(PZA-NMe2)Cl2] (7) were isolated and characterized. The ability of the ligands to coordinate in κ1-P vs κ2-P,E (E = O, N) modes was established by NMR experiments and complemented by DFT calculations. The X-ray crystal structure of the iodide analogue of 7 was obtained. Complexes 6–9 were tested as catalysts for acetophenone reduction using different hydrogen sources under mild conditions, and preliminary results are here described.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.